Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2586 | TNF-a | 100 | ng/mL | 1 | IL-1RA | 51.0 | 54 | ||||
N2586 | PD184352 | 0.1 | uM | TNF-a | 100 | ng/mL | 1 | IL-1RA | 54.0 | 59 | |
N2586 | Lestaurtinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | IL-1RA | 52.0 | 63 | |
N2586 | Ruxolitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | IL-1RA | 53.0 | 61 | |
N2586 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | IL-1RA | 48.0 | 48 | |
N2586 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 1 | IL-1RA | 39.0 | 47 | |
N2586 | EO1428 | 1.0 | uM | 1 | IL-1RA | 25.5 | 30 | ||||
RA2159 | IL-1 alpha | 100 | ng/mL | 1 | IL-1RA | 41.0 | 71 | ||||
RA2159 | PD184352 | 0.1 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL-1RA | 37.5 | 50 | |
RA2159 | Lestaurtinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL-1RA | 27.0 | 57 | |
RA2159 | Ruxolitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL-1RA | 46.0 | 50 | |
RA2159 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL-1RA | 46.0 | 65 | |
RA2159 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL-1RA | 25.0 | 73 | |
RA2159 | PI103 | 0.1 | uM | 1 | IL-1RA | 26.0 | 63 | ||||
N2586 | IL-1 alpha | 100 | ng/mL | 1 | IL-1RA | 53.0 | 65 | ||||
N2586 | PD184352 | 0.1 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL-1RA | 43.0 | 63 | |
N2586 | Lestaurtinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL-1RA | 44.0 | 64 | |
N2586 | Ruxolitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL-1RA | 53.5 | 54 | |
N2586 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL-1RA | 53.0 | 59 | |
N2586 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL-1RA | 35.0 | 39 | |
N2586 | PI103 | 0.1 | uM | 1 | IL-1RA | 24.0 | 49 | ||||
RA2159 | IL-6 | 100 | ug/mL | 1 | IL-1RA | 33.0 | 55 | ||||
RA2159 | PD184352 | 0.1 | uM | IL-6 | 100 | ug/mL | 1 | IL-1RA | 25.0 | 78 | |
RA2159 | Lestaurtinib | 0.3 | uM | IL-6 | 100 | ug/mL | 1 | IL-1RA | 23.0 | 85 | |
RA2159 | Ruxolitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 1 | IL-1RA | 32.5 | 68 |